IRVINE, Calif., June 15, 2011 /PRNewswire/ -- Irvine Pharmaceutical Services is pleased to announce the exciting addition of Dr. Assad Al-Ammar to Irvine‘s analytical management team as the new Manager of Minerals. Dr. Al-Ammar brings with him over 25 years of analytical experience. Dr. Al-Ammar has over fourteen years of experience with ICP-MS and has fifteen peer-reviewed research papers published in both the United States and Europe. Additionally, Dr. Al-Ammar has seven years experience with LC-ICP-MS and GC-ICP-MS speciation of toxic and pharmaceutically important elements and fifteen years of experience with ICP-AES, XRF, GC, and LC.
“With the upcoming changes to USP Chapter 231, Heavy Metals, Dr. Al-Ammar is a terrific addition to our minerals group,” said Yvonne Verburgt, Vice President of Business Development and Marketing. “We believe his extensive expertise and experience with ICP/ICP-MS methodology will even further strengthen the department’s level of scientific leadership and serve as a tremendous asset to our clients with the upcoming proposed new USP General Chapters, Elemental Impurities 232 and 233.”
Dr. Al-Ammar holds a Ph.D. in Analytical Chemistry from Glasgow University, United Kingdom, and was a postdoctoral fellow at the University of Massachusetts.
Learn more about Irvine and the upcoming proposed USP General Chapters, Elemental Impurities 232 and 233 at www.irvinepharma.com or call us today at 877-445-6654.
About Irvine Pharmaceutical Services, Inc.
Irvine Pharmaceutical Services, Inc., along with its affiliate Avrio Biopharmaceuticals, is a premier contract pharmaceutical development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Irvine and Avrio together provide full cGMP specialized product development services such as, preformulation / formulation development, analytical method development, aseptic fill and finish, stability testing and complete analytical CMC testing. Learn more at www.irvinepharma.com or call 877-445-6554.
SOURCE Irvine Pharmaceutical Services, Inc.
